Literature DB >> 24424314

Antiangiogenic therapy in patients with HER2-positive metastatic breast cancer: a case series.

Olivia Le Saux1, Benoît You2, Gilles Freyer2.   

Abstract

Entities:  

Keywords:  Aflibercept; Bevacizumab; HER2-positive; Metastatic breast cancer

Mesh:

Substances:

Year:  2013        PMID: 24424314     DOI: 10.1016/j.clbc.2013.11.005

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  1 in total

Review 1.  Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.

Authors:  Mei Liu; Zhiyang Li; Jingjing Yang; Yanyun Jiang; Zhongsi Chen; Zeeshan Ali; Nongyue He; Zhifei Wang
Journal:  Cell Prolif       Date:  2016-06-16       Impact factor: 6.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.